Revelstoke Capital Partners unveiled Revelstoke Frontier recently, a major move to drive AI utilizations and digitalization enhancements through the companies of the health services, healthcare technology, and wellness sectors in their portfolio. The setup intends to bring about operational excellence, ease of administrative tasks, cost reduction in the delivery of medical services, and betterment of patient outcomes and, at the same time, safeguarding the essential patient-provider relationships.
Also Read: Q2 Introduces AI-Powered Assistant to Streamline Banking Operations
To back the new direction, Revelstoke brought in Max Delahanty as Director of AI and Data Science and Wade Lowder as Managing Director of Technology, augmenting its Portfolio Transformation Group with specialists in AI, data science, technology infrastructure, and M&A integration. “Investing in technology, AI, and innovation is critical in furthering Revelstoke’s mission in reducing the cost of care, enabling access to care, elevating provider experience, and in delivering strong outcomes. We welcome Max and Wade to the Revelstoke team to continue deepening the firm’s expertise in advancing these capabilities within our portfolio companies,” said Simon Bachleda, Founder and Managing Partner of Revelstoke. The initiative underscores the firm’s commitment to leveraging emerging technologies to create long-term value across its healthcare investments.
